Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | -458.30% | -0.20% | 87.01% | 0.47% |
| Total Depreciation and Amortization | -2.80% | 0.59% | 0.15% | -2.46% | -0.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.75% | 377.13% | -0.20% | -174.04% | -0.48% |
| Change in Net Operating Assets | -- | -- | -0.21% | -- | -- |
| Cash from Operations | -2.75% | 116.91% | -0.21% | -62.59% | 0.48% |
| Capital Expenditure | 0.00% | 63.64% | 0.00% | -340.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | 63.64% | 0.00% | -340.00% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 40.49% | 0.00% | -16.51% | 0.00% |
| Issuance of Common Stock | 0.00% | 34.42% | 0.00% | -8.97% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 13.20% | 0.00% | -34.51% | 0.00% |
| Cash from Financing | -2.75% | 40.62% | 0.21% | -10.35% | -0.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 774.73% | -0.20% | -167.73% | -0.48% |